Site Map
Product Pages Catalogue Numbers 0301 - 0400
| Cat. No. | Product Name & Pharmacological Action |
|---|---|
| 0306 | (S)-(-)-5-Fluorowillardiine |
| Very potent AMPA agonist | |
| 0307 | (S)-(-)-5-Iodowillardiine |
| Highly potent, subtype selective kainate agonist | |
| 0310 | (RS)-4-Carboxy-3-hydroxyphenylglycine |
| 'Broad spectrum' EAA ligand | |
| 0312 | (RS)-(Tetrazol-5-yl)glycine |
| Highly potent NMDA receptor agonist | |
| 0320 | (S)-4-Carboxy-3-hydroxyphenylglycine |
| Group I antagonist/group II agonist | |
| 0321 | (RS)-4-Carboxyphenylglycine |
| 'Broad spectrum' EAA ligand | |
| 0322 | (R)-4-Carboxyphenylglycine |
| Moderately potent NMDA antagonist | |
| 0323 | (S)-4-Carboxyphenylglycine |
| Competitive group I mGlu antagonist/weak group II agonist | |
| 0324 | (RS)-3-Hydroxyphenylglycine |
| Group I mGlu agonist | |
| 0326 | (S)-3-Hydroxyphenylglycine |
| Group I mGlu agonist, active isomer | |
| 0328 | (R)-3-Carboxy-4-hydroxyphenylglycine |
| Moderately potent NMDA antagonist | |
| 0329 | (S)-3-Carboxy-4-hydroxyphenylglycine |
| Group I antagonist/group II agonist | |
| 0332 | L-CCG-lll |
| Potent, competitive uptake inhibitor | |
| 0333 | L-CCG-l |
| Potent group II mGlu agonist | |
| 0336 | (RS)-MCPG |
| Non-selective mGlu antagonist | |
| 0337 | (S)-MCPG |
| Active isomer of Cat. No. 0336 | |
| 0341 | L-AP6 |
| Selective agonist, highly potent | |
| 0342 | (RS)-3,5-DHPG |
| Selective group I mGlu agonist | |
| 0344 | GABA |
| Endogenous agonist | |
| 0347 | nor-Binaltorphimine dihydrochloride |
| Standard κ selective antagonist | |
| 0348 | 2-BFI hydrochloride |
| Potent, selective I2 ligand. Putative agonist | |
| 0351 | 1-Acetyl-4-methylpiperazine hydrochloride |
Nicotinic agonist |
|
| 0352 | 4-Acetyl-1,1-dimethylpiperazinium iodide |
Nicotinic agonist |
|
| 0355 | (±)-Acetylcarnitine chloride |
| Intermediate in lipid metabolism | |
| 0357 | N-Acetyltryptamine |
| Melatonin partial agonist (MT1/MT2). Also MT3 antagonist | |
| 0360 | (±)-1-(1,2-Diphenylethyl)piperidine maleate |
| NMDA antagonist, acts ion channel site | |
| 0361 | W-13 hydrochloride |
| Calmodulin antagonist | |
| 0366 | A-3 hydrochloride |
| Protein kinase inhibitor | |
| 0368 | W-5 hydrochloride |
| Calmodulin antagonist | |
| 0369 | W-7 hydrochloride |
| Calmodulin antagonist. Inhibits myosin light chain kinase | |
| 0370 | W-9 hydrochloride |
| Calmodulin antagonist | |
| 0373 | NBQX |
| Potent AMPA/kainate antagonist, more selective than CNQX (Cat. No. 0190) | |
| 0378 | A-7 hydrochloride |
| Calmodulin antagonist | |
| 0379 | SKF 97541 |
| Extremely potent GABAB agonist | |
| 0380 | Y-25130 hydrochloride |
| Potent, selective 5-HT3 antagonist | |
| 0382 | Arecaidine but-2-ynyl ester tosylate |
Muscarinic agonist |
|
| 0383 | Arecaidine propargyl ester tosylate |
Muscarinic agonist |
|
| 0384 | N-Acetyl-L-leucyl-L-leucyl-L-methional |
| Cathepsin inhibitor | |
| 0385 | SG 209 |
| K+ channel opener | |
| 0386 | 3-Methyl-GABA (2:1 salt with naphthalene-1,5-disulfonic acid) |
| Activator of GABA amino-transferase | |
| 0387 | (RS)-Atenolol |
β1 antagonist |
|
| 0388 | Ambenonium dichloride |
Cholinesterase inhibitor |
|
| 0389 | Arcaine sulfate |
| Competitive NMDA antagonist | |
| 0391 | Spaglumic acid |
| Selective mGlu3 agonist | |
| 0393 | S-(-)-Atenolol |
Active isomer |
|
| 0395 | N-Acetylglycyl-D-glutamic acid |
| Potent convulsant | |
| 0396 | H-9 dihydrochloride |
| Protein kinase inhibitor | |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | All |
[top]